Success Metrics

Clinical Success Rate
81.3%

Based on 13 completed trials

Completion Rate
81%(13/16)
Active Trials
4(14%)
Results Posted
38%(5 trials)
Terminated
3(11%)

Phase Distribution

Ph phase_2
3
11%
Ph early_phase_1
1
4%
Ph phase_1
9
32%
Ph not_applicable
10
36%

Phase Distribution

10

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution23 total trials
Early Phase 1First-in-human
1(4.3%)
Phase 1Safety & dosage
9(39.1%)
Phase 2Efficacy & side effects
3(13.0%)
N/ANon-phased studies
10(43.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

72.2%

13 of 18 finished

Non-Completion Rate

27.8%

5 ended early

Currently Active

4

trials recruiting

Total Trials

28

all time

Status Distribution
Active(5)
Completed(13)
Terminated(5)
Other(5)

Detailed Status

Completed13
unknown5
Recruiting3
Terminated3
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
4
Success Rate
81.3%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (4.3%)
Phase 19 (39.1%)
Phase 23 (13.0%)
N/A10 (43.5%)

Trials by Status

recruiting311%
terminated311%
unknown518%
withdrawn27%
active_not_recruiting14%
completed1346%
not_yet_recruiting14%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT07149207Phase 2

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Recruiting
NCT05593523

Fluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes

Active Not Recruiting
NCT04258566Not Applicable

Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

Terminated
NCT06979115

Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors

Not Yet Recruiting
NCT05735977Not Applicable

Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared

Completed
NCT06421103Not Applicable

Micro-dosing Indocyanine Green (ICG) in Children

Recruiting
NCT02478138Not Applicable

Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging

Completed
NCT06325618

Lymphedema, Low-grade Inflammation and the Vasculature in Turner Syndrome

Recruiting
NCT01886066Not Applicable

Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer

Completed
NCT02949726Phase 1

Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development

Completed
NCT04511026Phase 2

Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

Terminated
NCT05092750Phase 1

Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer

Withdrawn
NCT03888014

Intraoperative Fluorescence With Augmented Reality

Completed
NCT02910726Phase 2

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Completed
NCT02710240Phase 1

Indocyanine Green for Central Nervous System Tumors

Completed
NCT02111824Phase 1

A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy

Terminated
NCT01424215Not Applicable

The Use of Fluorescent Imaging for Intraoperative Cholangiogram During Laparoscopic Cholecystectomy

Completed
NCT04182152Not Applicable

Bronchoscopic ICG Injection and Percutaneous Hook-wire Techniques for Preoperative Lung Nodule Localization in VATS

Unknown
NCT03572998Not Applicable

Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment

Unknown
NCT02423148Not Applicable

Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
28